Clinical Trials Logo
  1. Home
  2. Multiple Sclerosis
  3. NCT05590533
  4. Details
NCT05590533 Clinical Trial

Turkish Version of F-2-MS

Multiple Sclerosis Clinical Trial

Official title:
Validity and Reliability of the Turkish Version of F-2-MS Scale

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05590533
Other study ID # 19.10.2022/F-2-MS
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date November 2022
Est. completion date May 2023

Study information
Verified date October 2022
Source Pamukkale University
Contact Ayse Ünal, Assoc. Prof.
Phone +90(258)2964297
Email pt.aunal@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aims of this study were to perform cultural adaptation of the F-2-MS and provide information regarding the factor structure, reliability and validity of the instrument in Turkish speaking patients with Multiple Sclerosis.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 180
Est. completion date May 2023
Est. primary completion date April 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: - Individuals aged between 20-65 years, with an EDSS score of 0-5, who have not had an attack in the last 2 months, who have no cognitive problems (a score of 6 or more according to the Hodkinson Mental Test), who do not have additional neurological diseases other than MS, and who volunteer to participate in the study will be included. Exclusion Criteria: - Individuals with an EDSS score greater than 5, who are in the attack period, who have vestibulosupressant or drug or alcohol use habits that cause neuropathy, and who have communication problems will be excluded from the study.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Cultural adaptation, reliability and validity
Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the F-2-MS

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Pamukkale University

Outcome
Type Measure Description Time frame Safety issue
Primary F-2-MS Scale F-2-MS is a novel scale to assess fatigue and perceived fatigability in patients with MS 10 minutes
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4